Your browser doesn't support javascript.
loading
Lysozyme binding with amikacin and levofloxacin studied by tritium probe, fluorescence spectroscopy and molecular docking.
Skrabkova, Hanna S; Chernysheva, Maria G; Baygildiev, Timur M; Shnitko, Alexey V; Kasperovich, Alexandra V; Egorova, Tolganay B; Badun, Gennadii A; Arutyunyan, Alexander M; Ksenofontov, Alexander L; Rodin, Igor A.
Affiliation
  • Skrabkova HS; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
  • Chernysheva MG; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia. Electronic address: chernyshevamg@my.msu.ru.
  • Baygildiev TM; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
  • Shnitko AV; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
  • Kasperovich AV; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
  • Egorova TB; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
  • Badun GA; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
  • Arutyunyan AM; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992, Moscow, Russia.
  • Ksenofontov AL; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992, Moscow, Russia.
  • Rodin IA; Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
Arch Biochem Biophys ; 751: 109848, 2024 01.
Article in En | MEDLINE | ID: mdl-38065249
Lysozyme complexes with amikacin and levofloxacin were studied by spectroscopy approaches as well as using a tritium probe. Tritium was used as a labeling agent to trace labeled compound concentration in a system of two immiscible liquids and in the atomic form to determine the possible position of the binding site. Co-adsorption of protein and drug at the liquid-liquid interface was analyzed by scintillation phase method that allowed us to directly determine the amount of protein and drug in the mixed adsorption layer. Also, tensiometric measuring of the interfacial tension was used for calculation of binding parameters accordingly to Fainerman model. The treatment of complexes with atomic tritium followed by trypsinolysis and analysis of tritium distribution in the lysozyme peptides reveals the binding sites, binding energies in which were analyzed using molecular docking. Formation of complexes with amikacin and levofloxacin preserves secondar structure of protein. However, the formation of complex with amikacin leads to the almost total loss of the enzymatic activity of lysozyme and the redshift of the maximum on the lysozyme fluorescence band. A slight decrease in the distribution coefficient of lysozyme in the presence of amikacin assumes that the complex has higher hydrophilicity in comparison to lysozyme without additives. The most favorable for binding were the positions of the active centers that included amino acids Asp52 and Glu35, as well as in the vicinity of peptide His15-Arg21, with the participation of amino acids Tyr20, Arg14. In the case of levofloxacin, the formation of lysozyme-ligand complex in aqueous solution is possible without changing the microenvironment of the active center of the protein. Binding of levofloxacin to the active center of the enzyme was the most favorable, but Asp52 and Glu35 that are responsible for the enzymatic activity of lysozyme, were not affected.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Muramidase Language: En Journal: Arch Biochem Biophys Year: 2024 Document type: Article Affiliation country: Russia Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Muramidase Language: En Journal: Arch Biochem Biophys Year: 2024 Document type: Article Affiliation country: Russia Country of publication: United States